Accellacare - Salisbury — Salisbury, North Carolina

Accellacare - Salisbury is a clinical research site located in Salisbury, North Carolina, United States 28144.

Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.

Accellacare - Salisbury has participated in 6 clinical trials with 4 currently active.

Therapeutic areas: SARS-CoV-2 Infection, COVID-19, SARS-CoV2.

Sponsors: BioNTech SE, Vaxart, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Accellacare - Salisbury?

Accellacare - Salisbury has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Accellacare - Salisbury conducted?

Accellacare - Salisbury has 6 clinical trials on record, with 4 currently active. Their work covers SARS-CoV-2 Infection, COVID-19, SARS-CoV2.

Is Accellacare - Salisbury accredited by Crixeo Health?

Yes — Accellacare - Salisbury holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Accellacare - Salisbury?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.